Annual Retained Earnings
-$384.18 M
-$44.64 M-13.15%
December 31, 2024
Summary
- As of March 13, 2025, CRDF annual retained earnings is -$384.18 million, with the most recent change of -$44.64 million (-13.15%) on December 31, 2024.
- During the last 3 years, CRDF annual retained earnings has fallen by -$124.37 million (-47.87%).
- CRDF annual retained earnings is now -829.74% below its all-time high of -$41.32 million, reached on December 31, 2010.
Performance
CRDF Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$384.18 M
-$11.79 M-3.17%
December 31, 2024
Summary
- As of March 13, 2025, CRDF quarterly retained earnings is -$384.18 million, with the most recent change of -$11.79 million (-3.17%) on December 31, 2024.
- Over the past year, CRDF quarterly retained earnings has dropped by -$11.79 million (-3.17%).
- CRDF quarterly retained earnings is now -781.18% below its all-time high of -$43.60 million, reached on December 31, 2011.
Performance
CRDF Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CRDF Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.2% | -3.2% |
| 3 y3 years | -47.9% | -41.9% |
| 5 y5 years | -83.9% | -41.9% |
CRDF Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.9% | at low | -47.9% | at low |
| 5 y | 5-year | -83.9% | at low | -83.9% | at low |
| alltime | all time | -829.7% | at low | -781.2% | at low |
Cardiff Oncology Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$384.18 M(+13.1%) | -$384.18 M(+3.2%) |
| Sep 2024 | - | -$372.39 M(+3.3%) |
| Jun 2024 | - | -$360.54 M(+3.4%) |
| Mar 2024 | - | -$348.76 M(+2.7%) |
| Dec 2023 | -$339.54 M(+13.9%) | -$339.54 M(+2.8%) |
| Sep 2023 | - | -$330.20 M(+3.0%) |
| Jun 2023 | - | -$320.47 M(+3.6%) |
| Mar 2023 | - | -$309.32 M(+3.8%) |
| Dec 2022 | -$298.10 M(+14.7%) | -$298.10 M(+2.9%) |
| Sep 2022 | - | -$289.83 M(+3.0%) |
| Jun 2022 | - | -$281.26 M(+3.9%) |
| Mar 2022 | - | -$270.81 M(+4.2%) |
| Dec 2021 | -$259.81 M(+12.2%) | -$259.81 M(+3.8%) |
| Sep 2021 | - | -$250.36 M(+2.8%) |
| Jun 2021 | - | -$243.44 M(+2.9%) |
| Mar 2021 | - | -$236.68 M(+2.2%) |
| Dec 2020 | -$231.50 M(+10.8%) | -$231.50 M(+2.9%) |
| Sep 2020 | - | -$224.89 M(+2.0%) |
| Jun 2020 | - | -$220.39 M(+3.5%) |
| Mar 2020 | - | -$212.99 M(+2.0%) |
| Dec 2019 | -$208.90 M(+8.7%) | -$208.90 M(+2.1%) |
| Sep 2019 | - | -$204.65 M(+2.1%) |
| Jun 2019 | - | -$200.50 M(+2.1%) |
| Mar 2019 | - | -$196.37 M(+2.2%) |
| Dec 2018 | -$192.19 M | -$192.19 M(+2.2%) |
| Sep 2018 | - | -$188.03 M(+2.0%) |
| Jun 2018 | - | -$184.25 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -$177.73 M(+2.7%) |
| Dec 2017 | -$173.05 M(+16.8%) | -$173.05 M(+1.5%) |
| Sep 2017 | - | -$170.47 M(+2.6%) |
| Jun 2017 | - | -$166.17 M(+5.1%) |
| Mar 2017 | - | -$158.12 M(+6.8%) |
| Dec 2016 | -$148.12 M(+36.0%) | -$148.12 M(+6.1%) |
| Sep 2016 | - | -$139.56 M(+7.9%) |
| Jun 2016 | - | -$129.36 M(+8.6%) |
| Mar 2016 | - | -$119.16 M(+9.4%) |
| Dec 2015 | -$108.89 M(+33.8%) | -$108.89 M(+7.3%) |
| Sep 2015 | - | -$101.50 M(+2.8%) |
| Jun 2015 | - | -$98.76 M(+11.5%) |
| Mar 2015 | - | -$88.57 M(+8.8%) |
| Dec 2014 | -$81.39 M(+21.4%) | -$81.39 M(+6.1%) |
| Sep 2014 | - | -$76.70 M(+7.5%) |
| Jun 2014 | - | -$71.32 M(+1.5%) |
| Mar 2014 | - | -$70.24 M(+4.8%) |
| Dec 2013 | -$67.04 M(+21.4%) | -$67.04 M(+1.6%) |
| Sep 2013 | - | -$66.01 M(+7.2%) |
| Jun 2013 | - | -$61.60 M(+9.4%) |
| Mar 2013 | - | -$56.32 M(+2.0%) |
| Dec 2012 | -$55.20 M(+26.6%) | -$55.20 M(+13.0%) |
| Sep 2012 | - | -$48.87 M(+1.4%) |
| Jun 2012 | - | -$48.21 M(+7.7%) |
| Mar 2012 | - | -$44.77 M(+2.7%) |
| Dec 2011 | -$43.60 M(+5.5%) | -$43.60 M |
| Dec 2010 | -$41.32 M | - |
FAQ
- What is Cardiff Oncology annual retained earnings?
- What is the all time high annual retained earnings for Cardiff Oncology?
- What is Cardiff Oncology annual retained earnings year-on-year change?
- What is Cardiff Oncology quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cardiff Oncology?
- What is Cardiff Oncology quarterly retained earnings year-on-year change?
What is Cardiff Oncology annual retained earnings?
The current annual retained earnings of CRDF is -$384.18 M
What is the all time high annual retained earnings for Cardiff Oncology?
Cardiff Oncology all-time high annual retained earnings is -$41.32 M
What is Cardiff Oncology annual retained earnings year-on-year change?
Over the past year, CRDF annual retained earnings has changed by -$44.64 M (-13.15%)
What is Cardiff Oncology quarterly retained earnings?
The current quarterly retained earnings of CRDF is -$384.18 M
What is the all time high quarterly retained earnings for Cardiff Oncology?
Cardiff Oncology all-time high quarterly retained earnings is -$43.60 M
What is Cardiff Oncology quarterly retained earnings year-on-year change?
Over the past year, CRDF quarterly retained earnings has changed by -$11.79 M (-3.17%)